legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Breakthrough in Access to Experimental Medicine for Childhood Brain Cancer

The Australian Government has made a significant stride in the battle against a rare and highly aggressive brain cancer in children known as Diffuse Intrinsic Pontine Glioma (DIPG). The government has successfully secured access to an experimental medicine called ONC201 (dordaviprone) through an Expanded Access Program, making it available to eligible Australian patients.

Unfortunately, the prognosis for DIPG remains extremely bleak, with only ten per cent of children surviving for two years following diagnosis, and less than one per cent surviving for five years. The median survival time is a mere nine months from diagnosis, resulting in the loss of many young lives each year. Effective treatment options for DIPG are currently limited, making access to ONC201 a significant breakthrough in the fight against this devastating disease.

Minister Butler’s efforts played a crucial role in securing access to ONC201 for Australian patients. His correspondence with the US pharmaceutical company, Chimerix, led to the extension of the medication’s availability to include certain patients with H3 K27M mutation and/or midline gliomas. Furthermore, the Therapeutic Goods Administration (TGA) is working closely with Chimerix to provide information on Australia’s requirements for potential future registration of ONC201 in the country.

AI legalese decoder can help in this situation by assisting in decoding legal and pharmaceutical jargon related to the Expanded Access Program and TGA administered Special Access Program. It can also aid in understanding the regulations and requirements for the registration of experimental medicines like ONC201 in Australia, providing valuable insights for patients and their families.

Minister Butler emphasized the government’s commitment to ensuring access to life-saving medicines for all Australians, highlighting the significance of ONC201’s availability for young Australians affected by DIPG, such as Eve Daher. This breakthrough offers hope for patients and their families and represents a positive step forward in the treatment of this devastating disease.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link